These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18212506)

  • 1. Mechanical and pharmacological approaches to investigate the pathogenesis of Marfan syndrome in the abdominal aorta.
    Chung AW; Yang HH; Yeung KA; van Breemen C
    J Vasc Res; 2008; 45(4):314-22. PubMed ID: 18212506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
    Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2007 Oct; 152(3):305-12. PubMed ID: 17641673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome.
    Syyong HT; Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2009 Nov; 158(6):1597-608. PubMed ID: 19814726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin reduces Marfan aortic dilation.
    McLoughlin D; McGuinness J; Byrne J; Terzo E; Huuskonen V; McAllister H; Black A; Kearney S; Kay E; Hill AD; Dietz HC; Redmond JM
    Circulation; 2011 Sep; 124(11 Suppl):S168-73. PubMed ID: 21911808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marfan syndrome decreases Ca2+ wave frequency and vasoconstriction in murine mesenteric resistance arteries without changing underlying mechanisms.
    Syyong HT; Chung AW; van Breemen C
    J Vasc Res; 2011; 48(2):150-62. PubMed ID: 20926894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress.
    Yang HH; van Breemen C; Chung AW
    Vascul Pharmacol; 2010; 52(1-2):37-45. PubMed ID: 19879959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of tissue doppler imaging for assessing aortic wall stiffness in children with the Marfan syndrome.
    Harada K; Yasuoka K; Shimada Y
    Am J Cardiol; 2004 Apr; 93(8):1072-5. PubMed ID: 15081464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the Thoracic Aorta by Region and Sex in a Murine Model of Marfan Syndrome.
    Jiménez-Altayó F; Siegert AM; Bonorino F; Meirelles T; Barberà L; Dantas AP; Vila E; Egea G
    Front Physiol; 2017; 8():933. PubMed ID: 29187826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Marfan syndrome: abnormal aortic elastic properties.
    Hirata K; Triposkiadis F; Sparks E; Bowen J; Wooley CF; Boudoulas H
    J Am Coll Cardiol; 1991 Jul; 18(1):57-63. PubMed ID: 2050942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.
    Lee JJ; Galatioto J; Rao S; Ramirez F; Costa KD
    Ann Biomed Eng; 2016 Oct; 44(10):2994-3006. PubMed ID: 27090893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome.
    Baumgartner D; Baumgartner C; Mátyás G; Steinmann B; Löffler-Ragg J; Schermer E; Schweigmann U; Baldissera I; Frischhut B; Hess J; Hammerer I
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):730-9. PubMed ID: 15821637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome.
    Marque V; Kieffer P; Gayraud B; Lartaud-Idjouadiene I; Ramirez F; Atkinson J
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1184-9. PubMed ID: 11451749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of spinal circulation in Marfan syndrome].
    Ki'riakov VA; Odinokova VA
    Sov Med; 1989; (10):79-82. PubMed ID: 2617349
    [No Abstract]   [Full Text] [Related]  

  • 17. Paracrine effects of endothelial cells in a diabetic mouse model: capacitative calcium entry stimulated thromboxane release.
    Okon EB; Golbabaie A; Breemen Cv
    Horm Metab Res; 2008 Sep; 40(9):645-50. PubMed ID: 18792877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ageing in Marfan syndrome.
    Hasan A; Poloniecki J; Child A
    Int J Clin Pract; 2007 Aug; 61(8):1308-20. PubMed ID: 17627709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marfan syndrome: from molecular pathogenesis to clinical treatment.
    Ramirez F; Dietz HC
    Curr Opin Genet Dev; 2007 Jun; 17(3):252-8. PubMed ID: 17467262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B; Malfait F; Loeys B; De Paepe A
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.